Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Search
Sign in
Sign up
State Street’s
ARS Pharmaceuticals
SPRY
Stock Holding History
State Street’s Portfolio
SPRY Stock Details
SPRY Fund Activity
Bought
Maintained
Sold
Shares
Quarter
Market Value
Status
Shares
Change in
Stake
Trade Value
Portfolio Weight
Portfolio Position
2026
Q1
$29.3M
Buy
3,644,966
+421,385
+13%
+$4.04M
﹤0.01%
2030
2025
Q4
$37.6M
Buy
3,223,581
+328,325
+11%
+$3.19M
﹤0.01%
1903
2025
Q3
$29.1M
Buy
2,895,256
+700,763
+32%
+$10.1M
﹤0.01%
2033
2025
Q2
$38.3M
Buy
2,194,493
+163,259
+8%
+$2.36M
﹤0.01%
1824
2025
Q1
$25.6M
Sell
2,031,234
-718,667
-26%
-$8.65M
﹤0.01%
1987
2024
Q4
$29M
Buy
2,749,901
+700,359
+34%
+$9.81M
﹤0.01%
2008
2024
Q3
$29.7M
Buy
2,049,542
+193,321
+10%
+$2.3M
﹤0.01%
1983
2024
Q2
$15.8M
Buy
1,856,221
+251,671
+16%
+$2.23M
﹤0.01%
2288
2024
Q1
$16.4M
Buy
1,604,550
+1,027,570
+178%
+$7.66M
﹤0.01%
2290
2023
Q4
$3.16M
Buy
576,980
+40,820
+8%
+$179K
﹤0.01%
3152
2023
Q3
$2.03M
Buy
536,160
+97,609
+22%
+$641K
﹤0.01%
3327
2023
Q2
$2.94M
Buy
438,551
+309,360
+239%
+$2.06M
﹤0.01%
3238
2023
Q1
$841K
Buy
129,191
+43,300
+50%
+$333K
﹤0.01%
3593
2022
Q4
$733K
Buy
85,891
+18,300
+27%
+$119K
﹤0.01%
3639
2022
Q3
$357K
Hold
67,591
–
–
﹤0.01%
3902
2022
Q2
$287K
Sell
67,591
-276,603
-80%
-$965K
﹤0.01%
4052
2022
Q1
$1.21M
Buy
344,194
+20,181
+6%
+$87.9K
﹤0.01%
3746
2021
Q4
$2.16M
Buy
324,013
+18,944
+6%
+$154K
﹤0.01%
3609
2021
Q3
$3.04M
Buy
305,069
+80,750
+36%
+$1.99M
﹤0.01%
3489
2021
Q2
$6.93M
Buy
224,319
+32,155
+17%
+$1.03M
﹤0.01%
3089
2021
Q1
$8.38M
Buy
+192,164
New
+$9.09M
﹤0.01%
2825
Other funds holding SPRY
RCM
RA Capital Management
Boston, Massachusetts
$9.44B AUM
157.3%
1-Year Est. Return
O
OrbiMed
New York
$5.05B AUM
125.28%
1-Year Est. Return
RCMNY
Rubric Capital Management (New York)
New York
$9.44B AUM
68.42%
1-Year Est. Return
DM
Deerfield Management
New York
$8.48B AUM
99.04%
1-Year Est. Return
Millennium Management
New York
$240B AUM
35.51%
1-Year Est. Return
BlackRock
New York
$5.72T AUM
30.48%
1-Year Est. Return
Aberdeen Group
Edinburgh, United Kingdom
$61.9B AUM
29.81%
1-Year Est. Return
SOCM
SR One Capital Management
Wayne, Pennsylvania
$915M AUM
209.71%
1-Year Est. Return
Franklin Resources
San Mateo, California
$408B AUM
30.18%
1-Year Est. Return
TCM
Tyro Capital Management
Miami, Florida
$921M AUM
60.37%
1-Year Est. Return
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Theme
Close